Thomas H Schindler

[Thomas H Schindler @h_hellmut]

FDA Approval of 18F-Flurpiridaz Is for PET: Stepping into a New Area of Myocardial Perfusion Imaging? https://t.co/fHGBMwBBxW

[Thomas H Schindler @h_hellmut]

@cingolani_oscar @hopkinsheart @CiccaroneCenter @TLeucker @rblument1 @armin_zadeh Thanks very much!!! Very honored to have given this talk at Grand Rounds at Johns Hopkins Medicine, and seeing many friends again! 🙂

[Oscar Cingolani, MD @cingolani_oscar]

Terrific @hopkinsheart Grand Rounds today by Dr. Thomas Schindler @h_hellmut on PET/CT assessment of coronary morphology and flow. @CiccaroneCenter

[Thomas H Schindler @h_hellmut]

@Steph_Achenbach looks like that interventional studies are going back and forth in their results!🙂

[Thomas H Schindler @h_hellmut]

Needs to be faster if you want to lose some calories Stephan ! :)

[Stephan Achenbach @Steph_Achenbach]

On my way to on-call STEMI. Lucky to be living in a small town (w/ large hospital) where I can bike to the cath lab on a summer night (or winter, when the time comes) and still arrive before the patient

#cardiotwitter @escardio @HolgerNef @JEscaned @ESC_President @Drroxmehran

[Stephan Achenbach @Steph_Achenbach]

On my way to on-call STEMI. Lucky to be living in a small town (w/ large hospital) where I can bike to the cath lab on a summer night (or winter, when the time comes) and still arrive before the patient

#cardiotwitter @escardio @HolgerNef @JEscaned @ESC_President @Drroxmehran

[Thomas H Schindler @h_hellmut]

Angiography-Derived FFR as Novel Parameter in Assessing Flow-Limiting CAD? Commentary https://t.co/vT2gjggYPg
on Westra et al.
https://t.co/m2TYsIecX3
Comparable diagnostic accuracy of QFR and invasively measured FFR but low concordance with PET determined MFR.

[Thomas H Schindler @h_hellmut]

Published in IJC Heart & Vasculature.
DOI: https://t.co/LaikhYrFEr
In this analysis in a symptomatic cardio-metabolic risk population, 54% had evidence of coronary microvascular dysfunction (CMD) as determined with PET. Thereof, 65% had classical CMD and 35% had endogen CMD.

[Thomas H Schindler @h_hellmut]

@DavidLBrownMD David, you did not ask me to return to California!!!:)

[Less-Is-More Cardiologist @DavidLBrownMD]

Good morning California!

[Thomas H Schindler @h_hellmut]

@DrMarthaGulati Normally, editors take out insulting comments but sometimes they may miss it. I always tell my fellows, "when you want to publish, you need thick skin and don't take reviewer comments personally". Just keep going .....

[theodoreabraham @tabrahammd]

Hellow Tweetverse! Good morning to all! @ucsf_echo @UCSF @UCSFMedicine @UCSFCardiology @ASE360 @hcmsociety @ethanweiss @RWASECEO @SLittleMD @ray_stainback @mswami001 @ErinMichos @iamritu @MasriAhmadMD @scauduro

[Thomas H Schindler @h_hellmut]

@MIRimaging Farrokh leading MIR NUC to best in the nation!!!

[WashU Medicine Mallinckrodt Institute of Radiology @WashUMedMIR]

This #WomensHistoryMonth, we're shining a spotlight on #RadWomen leaders at MIR.

Farrokh Dehdashti, MD, is the Drs. Barry A. & Marilyn J. Siegel Professor of Radiology, senior vice chair and division director of nuclear medicine.

[Thomas H Schindler @h_hellmut]

@rblument1 great news Wendy! Most deserving!!!👍👍👍

[Thomas H Schindler @h_hellmut]

@PamelaWoodardp @RSNA @DrGMcGinty @jimmychoo Excellent for cardiorespiratory fitness!!!👍

[Thomas H Schindler @h_hellmut]

18F-FDG Positron Emission Tomography in Myocardial Viability Assessment: A Practical and Time Efficient Protocol https://t.co/oybnIdTLfU

[Thomas H Schindler @h_hellmut]

@lesleejshaw I believe this will be an ongoing investigation for years to come.... In the end there is much clinical reasoning when you weigh in all factors such as age, symptoms, comorbities, LVEF etc. for optimal patient care!

[Leslee Shaw @lesleejshaw]

Ha, we will see!

[Thomas H Schindler @h_hellmut]

@TomLuscher Historical and still unbelievable success Tom!!! They can start setting up a monument for you at the ESC or in Zuerich!!!